Clearmind Medicine Inc. - Common Shares (CMND)

Last Price0.7989

Change-0.0551 (-6.45%)

NASDAQ · Last Trade: Apr 23rd, 1:13 PM EDT

Detailed Quote

Previous Close	0.8540
Open	0.8125
Bid	0.7988
Ask	0.8089
Day's Range	0.7513 - 0.8349
52 Week Range	0.0661 - 3.250
Volume	1,284,827
Market Cap	-
PE Ratio (TTM)	-
EPS (TTM)	-
Dividend & Yield	N/A (N/A)
1 Month Average Volume	12,714,528

About Clearmind Medicine Inc. - Common Shares (CMND)

Clearmind Medicine Inc is a biotechnology company focused on developing innovative therapeutics aimed at treating mental health disorders. The company leverages its expertise in psychedelic research to create novel compounds that can address conditions such as depression, anxiety, and addiction. By combining advanced scientific approaches with an emphasis on safety and efficacy, Clearmind aims to revolutionize the way mental health issues are treated, ultimately improving patient outcomes and quality of life. Their commitment to rigorous clinical trials and research positions them at the forefront of the emerging field of psychedelic medicine. Read More

News & Press Releases

Why Is Clearmind Medicine Stock Sliding On Wednesday?benzinga.com

Clearmind Medicine Inc. (NYSE: CMND) faces a price correction Wednesday following a massive rally. Read more on the impact of CMND-100 trial results and new executive orders.

Via Benzinga · April 22, 2026

Top movers in Tuesday's sessionchartmill.com

Via Chartmill · April 21, 2026

Unusual volume stocks are being observed in Tuesday's session.chartmill.com

Via Chartmill · April 21, 2026

These stocks are moving in today's sessionchartmill.com

Via Chartmill · April 21, 2026

Traders are paying attention to the gapping stocks in Tuesday's session.chartmill.com

Via Chartmill · April 21, 2026

Stay updated with the stocks that are on the move in today's pre-market session.chartmill.com

Via Chartmill · April 21, 2026

Kartoon Studios (NYSE: TOON) Gaining Momentum Alongside CMND, ENVB, WLDS, ANY – See Why?

Kartoon Studios (NYSE: TOON) is entering what many investors view as a pivotal transition year, with its latest podcast appearance offering fresh insight into the company’s growth trajectory and 2026 outlook. The stock has begun to reflect that momentum, closing at $0.6826 on 466K shares on Friday, April 17, 2026, marking a 17.89% gain over the past 30 days from its $0.565 low . The recent price action, combined with increasing volume and investor awareness, suggests TOON is starting to build traction as attention shifts toward its expanding production pipeline, streaming growth, and upcoming franchise catalysts.

Via AB Newswire · April 20, 2026

Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health Care

Vancouver, Canada, April 20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage psychedelic biotech company focused on the discovery and development of novel, non-hallucinogenic, neuroplastogen-derived therapeutics to solve major under-treated health problems, today commended President Donald J. Trump’s Executive Order signed on April 18, 2026, titled Accelerating Medical Treatments for Serious Mental Illness, which directs the U.S. Food and Drug Administration (FDA) to prioritize review processes for certain psychedelic drugs designated as breakthrough therapies and expands patient access pathways.

By Clearmind Medicine Inc. · Via GlobeNewswire · April 20, 2026

Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session.chartmill.com